Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Public Assessment Report Decentralised Procedure Combisal 25 microgram/50 microgram per metered dose pressurised inhalation, suspension Combisal 25 microgram/125 microgram per metered dose pressurised inhalation, suspension Combisal 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Salmeterol xinafoate and fluticasone propionate) Procedure Number(s): UK/H/6076/001-003/DC UK Licence No(s): PL 36532/0001-0003 Genetic PAR Combisal 25/50, 25/125 and 25/250 microgram per metered dose pressurised inhaler, suspension UK/H/6076//001-003/DC 2 LAY SUMMARY Combisal 25 microgram/50 microgram per metered dose pressurised inhalation, suspension Combisal 25 microgram/125 microgram per metered dose pressurised inhalation, suspension Combisal 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Salmeterol (as xinaofoate) 25 microgram/fluticasone propionate 50, 125 or 250 microgram per metered dose pressurised inhalation, suspension) This is a summary of the Public Assessment Report (PAR) for Combisal 25 microgr
Public Assessment Report Decentralised Procedure Combisal 25 microgram/50 microgram per metered dose pressurised inhalation, suspension Combisal 25 microgram/125 microgram per metered dose
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}